Navigation Links
Syngenta holds Annual General Meeting
Date:4/21/2009

BASEL, Switzerland, April 21 /PRNewswire-FirstCall/ -- At the Annual General Meeting of Syngenta AG on 21 April 2009, the shareholders approved all the motions proposed by the Board of Directors.

Shareholders approved a dividend of CHF 6.00 per share for the business year 2008, an increase of 25% over the previous year. Shareholders also approved a reduction of the share capital to CHF 9,459,984.90 through the cancellation of 2,315,008 shares, which the Company repurchased in 2008 within the scope of the approved repurchase program.

Rupert Gasser and Peter Doyle stepped down from the Board, having reached the statutory maximum age of 70. Syngenta Chairman Martin Taylor said: "On behalf of the Board, I would like to thank both for their outstanding contribution to the Company. Their considerable experience and sound guidance have been instrumental in our collective success."

Stefan Borgas, CEO of Lonza, and David Lawrence, former Head of R&D at Syngenta, were elected as new members of the Board of Directors.

Peggy Bruzelius, Pierre Landolt and Jurg Witmer were re-elected to the Board. Following a recent decision of the Board of Directors, Jurg Witmer takes the role of Vice Chairman of the Board of Directors with immediate effect.

Syngenta is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Note to the editor:

The speech of the Chairman, the presentation of the CEO and images of the Annual General Meeting and the newly elected Board members can be found at www.syngenta.com/agm2009.

    Syngenta International AG

    Media Office
    CH-4002 Basel
    Switzerland
    Tel:   +41 61 323 23 23
    Fax:   +41 61 323 24 24

    www.syngenta.com

    Media contact:
    Medard Schoenmaeckers
    Switzerland   +41 61 323 2323

    Analyst/Investor contacts:
    Jennifer Gough
    Switzerland   +41 61 323 5059
    USA           +1 202 737 6521

    John Hudson
    Switzerland   +41 61 323 6793
    USA           +1 202 737 6520


'/>"/>
SOURCE Syngenta
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta Licenses Chromatin Gene Stacking Technology
2. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
3. Syngenta To Build Major Global Biotech Research Center in Beijing, China
4. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
5. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
6. Syngenta Enters Into Research Collaboration With Anhui Academy, China
7. Syngenta Board Proposes Stefan Borgas to Become New Director
8. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
9. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
10. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
11. So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), a ... announced it has issued a scientific white paper entitled “Results from recent Alzheimer’s ... commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio and ...
(Date:2/22/2017)... Feb. 22, 2017 Aethlon Medical, Inc. (Nasdaq: ... a study that validated the ability of the Aethlon ... with increased mortality in immune-suppressed sepsis patients and also ... The objective of the study was to validate ... Epstein-Barr virus (EBV) and Herpes Simplex virus 1 (HSV1) ...
(Date:2/21/2017)... Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... protect and restore the health of patients, intends to report operational ... on Thursday, March 2, 2017, and to host a conference call ... the call is as follows: U.S. (toll free): 1-888-347-5280 ... ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... that Dr. Trevor Heritage has joined its executive team to lead the development ... to provide insights to help improve the diagnosis and treatment of cancer. The ...
Breaking Biology Technology:
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):